Detailed price information for Aethlon Medical Inc (AEMD-Q) from The Globe and Mail including charting and trades.
Detailed price information for Xenon Pharmaceuticals Inc (XENE-Q) from The Globe and Mail including charting and trades.
North Immunology will emerge into the public biotech world through a reverse merger with Aethlon Medical (AEMD).
Aethlon Medical (NASDAQ:AEMD) shares surged more than 400% in pre-market trading on Thursday after the company announced a definitive merger agreement with privately held biotechnology company North Immunology. The all-stock transaction will combine the businesses through Aethlon’s wholly owned subsidiaries, Nighthawk Merger Sub Corp.
Aethlon Medical, Inc. (Nasdaq: AEMD) ("Aethlon" or the "Company") today announced that it has entered into a definitive merger agreement (the "Agreement") for an all-stock transaction with North Immunology, Inc. ("North Immunology"), Nighthawk Merger Sub Corp., a wholly owned subsidiary of Aethlon, and Nighthawk Second Merger Sub, LLC, a wholly owned subsidiary of Aethlon. North Immunology is a privately held biotechnology company developing bispecific antibodies that target orthogonal inflammat
This is the newest page. Registered accounts read further back.